Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT04722978. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
ClinicalTrials.gov study NCT06231693. IPD Sharing: YES. Countries: 1. Publications: 0.
An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT03243331. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06418126. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imipramine on ER+ve and Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03122444. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03168880. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03362060. IPD Sharing: NO. Countries: 1. Publications: 0.
Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer for Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT02001519. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT04145947. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT05546255. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment
ClinicalTrials.gov study NCT04085276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
ClinicalTrials.gov study NCT04362462. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Feasibility of a Lifestyle Intervention for Women With Triple-negative Breast Cancer Under Neoadjuvant Immunotherapy
ClinicalTrials.gov study NCT07311083. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02247037. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03606967. IPD Sharing: YES. Countries: 1. Publications: 0.
Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02996825. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
ClinicalTrials.gov study NCT02954874. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Study of Camrelizumab Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT04907344. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inh
ClinicalTrials.gov study NCT05957042. IPD Sharing: NO. Countries: 1. Publications: 0.
A Window of Opportunity Study of Methionine Deprivation in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03186937. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.